Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what work is being done with the Secretary of State for Education to address the additional workload of teaching assistants that are providing medical attention for disabled and severely ill children in SEND schools.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Schools White Paper, Every child achieving and thriving, and the consultation on Special Educational Needs and Disabilities (SEND) reforms have now been published, as of 23 February. The White Paper and the consultation are available, respectively, at the following two links:
https://www.gov.uk/government/publications/every-child-achieving-and-thriving
These documents set out our ambitions to transform outcomes for children, young people, and their families who have been let down for far too long. The Department for Health and Social Care and NHS England have worked closely with the Department for Education on the reforms, and continued close partnership between health, social care, and education will be needed to realise the opportunity created by these crucial reforms.
The Government is currently consulting on proposed updates to the statutory guidance on supporting pupils with medical conditions at school, with further information available at the following link:
The Government will publish non-statutory guidance to clarify the roles and responsibilities of health and education in supporting pupils with medical conditions in education settings. Schools are responsible for managing their resources and budgets. They must comply with their statutory duties, including those under the Equality Act and the duty under section 100 of the Children and Families Act 2014 to make arrangements for supporting pupils with medical conditions.
Integrated care boards (ICBs) have various statutory duties under the Children and Families Act 2014 to work with local authorities, including on: identifying and notifying where a child or young person has potential SEND; joint commissioning; participating in education, health and care assessments and plans; and securing health provision. Reform proposals include the creation of New Specialist Provision Packages for children and young people with complex needs, which set out exactly what support and resources are required for specific needs. These will be developed and reviewed by an Independent Expert Panel with education and health co-chairs, and shaped through testing with parents. For children under five years old with complex needs, we will introduce a fast track for a Specialist Provision Package and Education, Health and Care Plan.
The NHS Medium Term Planning Framework for 2026/27 to 2028/29, published October 2025, included, for the first time, a clear requirement for ICBs and providers to meet their statutory SEND duties and support the Government’s SEND reform plans. The framework is available at the following link:
Each ICB is also required to have an executive lead for children and young people with SEND. ICBs will need to work alongside local authorities to develop Local SEND Reform Plans, which will set out each local area’s approach to implementing SEND reforms, tailored to local context and need. These plans will lay the foundation for long-term reform, set how partners will work together, and enable ongoing monitoring of progress, including introduction of the new Experts at Hand service.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the level of his Department's role in SEND provision, especially for children with a) disabilities and life limiting-illnesses and b) children who need regular medication throughout the school day.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Schools White Paper, Every child achieving and thriving, and the consultation on Special Educational Needs and Disabilities (SEND) reforms have now been published, as of 23 February. The White Paper and the consultation are available, respectively, at the following two links:
https://www.gov.uk/government/publications/every-child-achieving-and-thriving
These documents set out our ambitions to transform outcomes for children, young people, and their families who have been let down for far too long. The Department for Health and Social Care and NHS England have worked closely with the Department for Education on the reforms, and continued close partnership between health, social care, and education will be needed to realise the opportunity created by these crucial reforms.
The Government is currently consulting on proposed updates to the statutory guidance on supporting pupils with medical conditions at school, with further information available at the following link:
The Government will publish non-statutory guidance to clarify the roles and responsibilities of health and education in supporting pupils with medical conditions in education settings. Schools are responsible for managing their resources and budgets. They must comply with their statutory duties, including those under the Equality Act and the duty under section 100 of the Children and Families Act 2014 to make arrangements for supporting pupils with medical conditions.
Integrated care boards (ICBs) have various statutory duties under the Children and Families Act 2014 to work with local authorities, including on: identifying and notifying where a child or young person has potential SEND; joint commissioning; participating in education, health and care assessments and plans; and securing health provision. Reform proposals include the creation of New Specialist Provision Packages for children and young people with complex needs, which set out exactly what support and resources are required for specific needs. These will be developed and reviewed by an Independent Expert Panel with education and health co-chairs, and shaped through testing with parents. For children under five years old with complex needs, we will introduce a fast track for a Specialist Provision Package and Education, Health and Care Plan.
The NHS Medium Term Planning Framework for 2026/27 to 2028/29, published October 2025, included, for the first time, a clear requirement for ICBs and providers to meet their statutory SEND duties and support the Government’s SEND reform plans. The framework is available at the following link:
Each ICB is also required to have an executive lead for children and young people with SEND. ICBs will need to work alongside local authorities to develop Local SEND Reform Plans, which will set out each local area’s approach to implementing SEND reforms, tailored to local context and need. These plans will lay the foundation for long-term reform, set how partners will work together, and enable ongoing monitoring of progress, including introduction of the new Experts at Hand service.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to promote (a) culturally competent and (b) community-led prevention measures for older black men.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
This Government recognises the evidence that men of Black ethnicity are at a higher risk of some diseases. Tackling these inequalities is a top priority for the Government.
For example, black men are at higher risk of cardiovascular disease yet evidence shows that men in Black and Mixed ethnic groups are the least likely to receive lipid-lowering therapy or reach blood pressure targets. The National Health Service is tackling these inequalities through the Core20PLUS5 programme, a national approach to inform action to reduce healthcare inequalities in the most deprived areas. Hypertension and lipid management are one of the top clinical priorities for the framework, and the NHS is supporting systems where the burden of undiagnosed hypertension and untreated cholesterol is highest. Community based delivery models, such as pharmacy blood pressure checks and BP@Home, are also increasing access for underserved groups, including those in deprived and ethnically diverse communities.
Prostate cancer is another example where incidence rates are higher among Black men. We are jointly delivering the £42 million TRANSFORM trial with Prostate Cancer UK, with £16 million from the Department, which aims to find better ways of detecting prostate cancer and address inequalities, ensuring at least 10% of those invited to participate are Black men. In November, the first men began receiving letters from their general practitioners, inviting them to join the landmark trial designed to make diagnosis earlier, safer, and more effective.
There are around 17,000 people living with sickle cell disease in England. It is the fastest growing genetic condition in the country and is more common in people of Black African and Black Caribbean heritage (77% of patients) and in more deprived communities (47% of patients). NHS England, through the Sickle Cell and Thalassemia Quality Improvement programme, has stepped up a programme of work aligned to the Government’s 10-Year Health Plan particularly focusing on the shift to prevention, through a new education programme, that aims to develop a series of e-learning modules, training and communication material, which will focus on improving the knowledge and awareness about the condition, including for black men.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Government response to the Women and Equalities Committee report on Tackling HIV transmission, HC 1663, what the basis is for the estimate that Cabotegravir injectable PrEP will impact 2,000 people; whether that figure is a cap on availability; and what steps his Department will take to ensure equitable access to injectable PrEP.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Cabotegravir pre-exposure prophylaxis (PrEP) was recommended by the National Institute for Health and Care Excellence (NICE) as a clinically and cost-effective use for people who cannot have oral PrEP on 5 November 2025.
NICE estimated that up to 1,000 people would be eligible to receive cabotegravir injectable as PrEP but there is no cap on the number of people who may be eligible and therefore require and receive cabotegravir PrEP.
The new HIV Action Plan, published on 1 December 2025, sets out how the Government will enable every level of the healthcare system to work together to engage everyone in prevention, testing and treatment, tackling stigma, and reaching our ambition to end new HIV transmissions by 2030.
The Government will work with local authorities to expand alternative and digital delivery routes for injectable PrEP and audit current HIV technologies to identify gaps in provision. The UK Health Security Agency will publish local PrEP indicators to support action to reduce inequalities.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many women in the UK have received Allergan breast implants.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Breast and Cosmetic Implant Registry (BCIR), set up in 2016, collects all implant data, and explant data where possible.
Practically, it is always difficult and often impossible to identify a model and product code on an explant. If explanted devices, or patients undergoing explant, cannot be linked to data collected at time of implant, then this often reduces explant data to 'patient, surgeon, location, date'. This in turn makes it impossible to monitor trends in explant/failure.
NHS England is in the process of clarifying and mandating the detail required in the BCIR and other device-related collections.
This will place a greater responsibility on trusts to either identify a device at the point of explant, or to identify the device from internal trust records created during the same patient's implant procedure. This will only be possible if the implant and explant are performed at the same trust. It is then the intention of NHS England to provide the same matching service for implant/explant where the trusts differ.
This solution will, when implemented, give a full, proactive picture of device longevity/risk, for the purposes of research and surveillance, alongside the existing ability to identify patients affected by a device recall notice.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many (a) breast implants and (b) PIP breast implants have ruptured and had to be removed in the last 10 years; and how many of those ruptured implants were not listed on the breast and cosmetic implant registry when implanted.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Breast and Cosmetic Implant Registry (BCIR), set up in 2016, collects all implant data, and explant data where possible.
Practically, it is always difficult and often impossible to identify a model and product code on an explant. If explanted devices, or patients undergoing explant, cannot be linked to data collected at time of implant, then this often reduces explant data to 'patient, surgeon, location, date'. This in turn makes it impossible to monitor trends in explant/failure.
NHS England is in the process of clarifying and mandating the detail required in the BCIR and other device-related collections.
This will place a greater responsibility on trusts to either identify a device at the point of explant, or to identify the device from internal trust records created during the same patient's implant procedure. This will only be possible if the implant and explant are performed at the same trust. It is then the intention of NHS England to provide the same matching service for implant/explant where the trusts differ.
This solution will, when implemented, give a full, proactive picture of device longevity/risk, for the purposes of research and surveillance, alongside the existing ability to identify patients affected by a device recall notice.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many reports of BIA-ALCL there have been in the UK; and which manufacturers of breast implants those reports have been associated with.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
As has been previously shared in evidence submitted to the Women and Equalities Select Committee in July 2025, with further information in the document attached, the Medicines and Healthcare product Regulatory Agency (MHRA) closely monitors Breast Implant Associated- Anaplastic Large Cell Lymphoma (BIA-ALCL), a cancer of the immune system, not a breast cancer, and publishes the output from this monitoring on the GOV.UK webpage, at the following link:
https://www.gov.uk/guidance/breast-implants-and-anaplastic-large-cell-lymphoma-alcl
The MHRA has developed, with advice from independent expert advisory group, a follow up strategy to collect further data on adverse incidents reporting BIA-ALCL. This has informed the information that is published on the MHRA webpage relating to BIA-ALCL which includes the most up to date number of confirmed reports of BIA-ALCL made to the MHRA, and the breakdown of the number of confirmed reports of primary BIA-ALCL cases by manufacturer of breast implant.
Please note that the data on the GOV.UK webpage should be interpreted in the context of the ‘Notes and limitations to the data’ section also provided on the webpage.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish a list of the research programmes that are underway on the safety of breast implants.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently funding any specific research into the safety of breast implants but welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money, and scientific quality.
The Department does not hold information related to breast implant safety research funded by other sources.
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Nursing and Midwifery Council on wait times for (a) general cases and (b) cases before the case examiner.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Nursing and Midwifery Council (NMC) is the independent regulator of nurses and midwives in the United Kingdom, and nursing associates in England. The NMC is independent of Government, directly accountable to Parliament and is responsible for operational matters concerning the discharge of its statutory duties. The United Kingdom’s model of healthcare professional regulation is founded on the principle of regulators operating independently from the Government. The Professional Standards Authority for Health and Social Care oversees the bodies that regulate health and care professionals in the UK, which includes the NMC.
As Minister of State for Health (Secondary Care), I monitor the NMC’s performance and meets with the organisation regularly, which includes discussion on the timeliness of the NMC’s fitness to practise processes. In line with the Ministerial Code, details of all ministerial meetings, including those with the NMC, are published quarterly on the GOV.UK website, at the following link:
https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings
Asked by: Sarah Owen (Labour - Luton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with relevant stakeholders on pay for specialist community public health nurses.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Specialist community public health nurses in England are typically paid on the National Health Service’s Agenda for Change (AfC) pay system.
Annual AfC pay awards are decided following recommendations from the independent NHS Pay Review Body (NHSPRB). We accepted the 2025/26 recommendations in full, and the Government has asked the NHSPRB to begin the 2026/27 pay round. Relevant stakeholders are invited to submit evidence to the NHSPRB to inform its deliberations.
Officials and ministers continue to engage with AfC unions on pay and contractual matters via the NHS Staff Council.